[Ovid] Cytokine Release Syndrome Biology and Management |
Reward10points
Best Answer
2024-4-27
|
| |
post
reply
points
1370
10
MRI Outcomes from the Long-term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results (P6-3.012)
10
Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of Tolebrutinib in Participants With Relapsing Multiple Sclerosis: 2.5-Year Results (S16.010)
10
Alcohol-associated liver disease – global epidemiology
10
Benefits of an Integrated Nurse Residency Program in the Neonatal Intensive Care Unit
20
What’s New: Updates on Cytomegalovirus in Solid Organ Transplantation
